CTKB Earnings Cytek Biosciences, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–12 of 12
| FY 2023 | 2023-12-31 | -0.09 | 2024-03-13 | 10-K |
| FY 2023 | 2022-12-31 | 0.02 | 2024-03-13 | 10-K |
| Q3 2022 | 2022-09-30 | -0.01 | 2022-11-09 | 10-Q |
| Q2 2022 | 2022-06-30 | -0.02 | 2022-08-10 | 10-Q |
| Q1 2022 | 2022-03-31 | 0.02 | 2022-05-12 | 10-Q |
| FY 2023 | 2021-12-31 | 0.00 | 2024-03-13 | 10-K |
| Q3 2022 | 2021-09-30 | 0.00 | 2022-11-09 | 10-Q |
| Q2 2022 | 2021-06-30 | 0.00 | 2022-08-10 | 10-Q |
| Q1 2022 | 2021-03-31 | 0.00 | 2022-05-12 | 10-Q |
| FY 2022 | 2020-12-31 | 0.10 | 2023-03-01 | 10-K |
| Q3 2021 | 2020-09-30 | 0.09 | 2021-11-12 | 10-Q |
| Q2 2021 | 2020-06-30 | 0.04 | 2021-09-03 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.